This study investigates pancreatic cancer with a high risk of recurrence. It focuses on patients who have had surgery to remove their tumor and are at risk of the disease coming back.
The study evaluates the safety and effectiveness of personalized treatments based on the molecular profile of the cancer. This approach helps determine the best-matched therapy for each patient.
- Who can participate: Adults aged 18 and older with pancreatic cancer, except those with neuroendocrine histology, who have had their pancreatic tumor surgically removed and meet specific health criteria may participate.
- Study details: Participants will receive therapy recommended by the Molecular Tumor Board, based on their cancer's molecular profile.
How understandable was the trial content above?
Hard to understand
Easy to understand